# Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray

> **NCT04843462** · NA · UNKNOWN · sponsor: **Lukas Pezawas** · enrollment: 70 (estimated)

## Conditions studied

- Major Depressive Disorder
- Therapy Resistant Depression

## Interventions

- **DEVICE:** edupression.com®
- **DRUG:** Esketamine nasal spray

## Key facts

- **NCT ID:** NCT04843462
- **Lead sponsor:** Lukas Pezawas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-29
- **Primary completion:** 2023-04-14
- **Final completion:** 2023-04-14
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04843462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04843462, "Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04843462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*